Saturday, June 3, 2017

ASH 2016: Dr. Anthony Mato on Real world Data on CLL (chronic lymphocytic leukemia)

I've posted on an interview with Dr. Anthony Mato from U. Penn when we talked at ASH 2016 about the real-world research he has been doing patients being treated with ibrutinib both in the community and academic settings, and not just within clinical trials. 

You can view my summary, watch the interview or read the transcript here.

Real world data is an important and challenging growing area of research, not just in CLL bit across many diseases

Here is a link to an interview with former FDA commissioner Robert Califf, MD discussing the pros and cons of real world data and best practices for research.

I am very fortunate to be working with Dr. Mato on our CLL patient journey research survey.

Labels: , , , , ,


Anonymous Anna said...

Nice post..

July 6, 2017 at 3:29 AM  

Post a Comment

Subscribe to Post Comments [Atom]

<< Home